Navigation Links
NextDocs Expands Customer Roster by More Than 10 Percent
Date:6/3/2013

CONSHOHOCKEN, Pa. and TOKYO, June 3, 2013 /PRNewswire/ -- NextDocs, the global leader in compliance solutions for regulated industries, announced today that it has expanded its client roster by more than 10 percent over the past six months, adding more than a dozen new life customers.  More than 100 leading life sciences and pharmaceutical companies already rely on NextDocs solutions including Astra Zeneca, McKesson, Sandoz, Sanofi and the National Cancer Center in Japan. 

The companies added to the NextDocs customer roster in include a Global 2000 specialty biopharmaceutical company with more than $4 billion in revenue;  a Fortune 500 healthcare products and medical device company with more than $1 billion in revenue;  a global pharmaceutical company with more than €1.2 billion in revenue; and one of the largest global clinical research organizations (CRO) with operations in more than 30 countries.  Approximately one-third of the new customers added in the past six months are global companies and firms headquartered in Japan. 

NextDocs is the global leader in providing Microsoft SharePoint-based compliance software solutions including regulatory document management, quality management and clinical management solutions.  NextDocs solutions enable businesses in regulated industries to achieve compliance with FDA and other regulations while automating processes, improving efficiency and dramatically reducing costs.  The solutions help manage the creation, approval, storage, and retrieval of critical compliance and quality related documents.

NextDocs has been named Microsoft's Life Sciences Partner of the Year for three years running and has been ranked as one of Inc. Magazine's fastest growing technology companies also for three years running.

Additional companies joining the NextDocs customer roster include a global healthcare company that designs and manufactures prescription and non-prescription products in over 20 countries; a leading research firm that has conducted thousands of drug safety, discovery and analytical studies;  a leading consulting firm providing IRB services; a contract manufacturer of clinical trial materials, pharmaceutical intermediates, and APIs for pharmaceutical companies; a publicly traded global drug development company; and a publicly traded emerging pharmaceutical company.

For more information on NextDocs Corporation and its software solutions, visit www.nextdocs.com.

For further information, contact:
Dan Cahill
(917) 617-0106
dcahill@roaringpr.com

 


'/>"/>
SOURCE NextDocs Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NextDocs Launches QuickStart for Emerging Growth Companies
2. NextDocs 6: The New Enterprise Standard for Regulated Content Management
3. NextDocs Corporation Announces Trial Exchange, a Clinical Portal Designed Specifically for Clinical Trial Sites and Integrated with eTMF
4. Edison Expands North American Healthcare Sector Coverage With Initiation of Coverage on Bellus Health
5. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
6. BioDrain Breaks into National Network of Ambulatory Surgical Centers and Expands Installations of its STREAMWAY System throughout the U.S.
7. Fortune 500 Pharmaceutical Company Expands Use of inContact Cloud Contact Center Software Across Multiple Divisions
8. Avillion Expands Leadership Team with Appointment of Ramani Varanasi as Chief Business Officer
9. Lehigh Valley Expands Fleet of Superbug-Slaying Robots
10. Tribogenics Expands X-Ray Development Team With Key Hires
11. CPhI China 2013 Increases Customer Content Services and Expands Thanks to a Double Digit Pharma Industry Growth Rate and a Burgeoning Generics Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017   Dynatronics Corporation (NASDAQ: ... Cynthia L. McHenry (Cyndi) as Vice ... leading Dynatronics manufacturing, distribution, and purchasing operations across ... CEO Kelvyn H. Cullimore, Jr. ... process conducted by the company as it continues ...
(Date:3/29/2017)... NetworkNewsWire Editorial Coverage  ... There are a number of advantages ... economic arguments also favor its legalization. The benefits include increased ... to legalize and regulate marijuana requires an ecosystem of support ... SING Profile ), American Cannabis Company (OTC: AMMJ), Kush Bottles, ...
(Date:3/29/2017)... AVIV, Israel , March 29, 2017 ... agreement in which Exeltis will obtain exclusive marketing rights for Neurim,s ... ... an age-appropriate drug targeted to treat sleep disorders in children with ... be the first sleep medication approved for children. The ...
Breaking Medicine Technology:
(Date:3/28/2017)... CO (PRWEB) , ... March 28, 2017 , ... ... reasonable assumption that in order to improve teacher quality, the field must first ... swinging from one popular reform to the next” and that decades of input- ...
(Date:3/28/2017)... NEW YORK (PRWEB) , ... March 28, 2017 ... ... development, NTX Technology™, is the first technology to directly address the resolution to ... Organization. NTX Technology™ is a patented compound of FDA and TTB approved ingredients ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... in state legislatures and Congress to protect parental rights and civil liberties, and ... safety in America. , The demonstration coincides with a press conference taking place ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... all holidays (IBT World Travel Trends Report). As travelers visit both urban destinations, ... in temperatures, and prolonged sun exposure. In response, the outdoor industry has blurred ...
(Date:3/28/2017)... PA (PRWEB) , ... March 28, 2017 , ... ... for and by physicians, announced today the launch of a free, public-facing tool ... Via Cost Analyzer (VCA) was developed to provide comparative information to patients, providers, ...
Breaking Medicine News(10 mins):